control group:sintilimab

2 trials

Sponsors

Affiliated Cancer Hospital of Shantou University Medical College, Oncology Department of PLA General Hospital

Conditions

Esophageal squamous cell carcinomalung cancer

Phase 2

Sintilimab with or without Chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma: a randomised controlled phase II trial

Active, not recruitingChiCTR2000040196

Affiliated Cancer Hospital of Shantou University Medical CollegeEsophageal squamous cell carcinoma

Start: 2020-11-25Updated: 2021-01-18

Study on the first-line treatment of advanced non-small cell lung cancer with sintilimab combined with chemotherapy guided by immune response related markers

RecruitingChiCTR2100044514

Oncology Department of PLA General Hospitallung cancer

Start: 2021-04-01Updated: 2021-09-20